Barclays PLC Has $443.84 Million Position in Marsh & McLennan Companies, Inc. $MRSH

Barclays PLC increased its holdings in shares of Marsh & McLennan Companies, Inc. (NYSE:MRSH) by 41.7% in the 3rd quarter, according to its most recent filing with the SEC. The fund owned 2,202,372 shares of the financial services provider’s stock after purchasing an additional 647,987 shares during the period. Barclays PLC owned approximately 0.45% of Marsh & McLennan Companies worth $443,844,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in MRSH. Hanson & Doremus Investment Management lifted its holdings in shares of Marsh & McLennan Companies by 31.3% during the third quarter. Hanson & Doremus Investment Management now owns 214 shares of the financial services provider’s stock worth $43,000 after buying an additional 51 shares during the last quarter. D.A. Davidson & CO. increased its position in Marsh & McLennan Companies by 1.2% during the third quarter. D.A. Davidson & CO. now owns 4,514 shares of the financial services provider’s stock worth $910,000 after acquiring an additional 54 shares during the period. OneAscent Wealth Management LLC boosted its holdings in Marsh & McLennan Companies by 6.1% in the 2nd quarter. OneAscent Wealth Management LLC now owns 1,046 shares of the financial services provider’s stock valued at $229,000 after purchasing an additional 60 shares during the period. Bank of Nova Scotia Trust Co. grew its position in Marsh & McLennan Companies by 6.7% in the 2nd quarter. Bank of Nova Scotia Trust Co. now owns 949 shares of the financial services provider’s stock worth $207,000 after purchasing an additional 60 shares during the last quarter. Finally, Ashton Thomas Securities LLC increased its holdings in shares of Marsh & McLennan Companies by 1.8% during the 3rd quarter. Ashton Thomas Securities LLC now owns 3,663 shares of the financial services provider’s stock worth $736,000 after purchasing an additional 63 shares during the period. Institutional investors and hedge funds own 87.99% of the company’s stock.

Insider Activity at Marsh & McLennan Companies

In other news, CEO John Q. Doyle sold 16,655 shares of the business’s stock in a transaction that occurred on Wednesday, March 4th. The stock was sold at an average price of $183.30, for a total value of $3,052,861.50. Following the transaction, the chief executive officer directly owned 116,811 shares of the company’s stock, valued at $21,411,456.30. The trade was a 12.48% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 0.35% of the stock is owned by insiders.

Analysts Set New Price Targets

MRSH has been the topic of a number of recent research reports. Morgan Stanley lifted their target price on Marsh & McLennan Companies from $190.00 to $195.00 and gave the stock an “equal weight” rating in a research report on Friday, January 30th. Evercore decreased their price objective on Marsh & McLennan Companies from $237.00 to $236.00 and set an “outperform” rating on the stock in a report on Wednesday, January 7th. JPMorgan Chase & Co. cut their target price on Marsh & McLennan Companies from $242.00 to $226.00 and set an “overweight” rating for the company in a research note on Wednesday, January 7th. Wells Fargo & Company lifted their price target on shares of Marsh & McLennan Companies from $199.00 to $203.00 and gave the stock an “equal weight” rating in a research note on Friday, January 30th. Finally, Royal Bank Of Canada restated a “sector perform” rating and issued a $200.00 price objective on shares of Marsh & McLennan Companies in a research note on Friday, January 30th. One equities research analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating, eleven have given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average price target of $216.18.

Marsh & McLennan Companies Trading Down 0.0%

Marsh & McLennan Companies stock opened at $184.91 on Friday. The firm has a market cap of $89.52 billion, a price-to-earnings ratio of 21.93, a P/E/G ratio of 2.51 and a beta of 0.74. Marsh & McLennan Companies, Inc. has a 52-week low of $170.37 and a 52-week high of $248.00. The company has a debt-to-equity ratio of 1.20, a current ratio of 1.10 and a quick ratio of 1.10.

Marsh & McLennan Companies (NYSE:MRSH) last posted its earnings results on Thursday, January 29th. The financial services provider reported $2.12 earnings per share for the quarter, topping the consensus estimate of $1.97 by $0.15. The business had revenue of $6.60 billion for the quarter, compared to analyst estimates of $6.52 billion. Marsh & McLennan Companies had a net margin of 15.42% and a return on equity of 31.60%. The firm’s quarterly revenue was up 8.7% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $1.87 EPS. On average, equities research analysts predict that Marsh & McLennan Companies, Inc. will post 9.61 EPS for the current year.

Marsh & McLennan Companies Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, May 15th. Stockholders of record on Thursday, April 9th will be issued a dividend of $0.90 per share. The ex-dividend date of this dividend is Thursday, April 9th. This represents a $3.60 annualized dividend and a dividend yield of 1.9%. Marsh & McLennan Companies’s dividend payout ratio (DPR) is presently 42.70%.

More Marsh & McLennan Companies News

Here are the key news stories impacting Marsh & McLennan Companies this week:

• Positive Sentiment: Recent quarterly results and a new dividend reinforce fundamentals: MMCo reported an earnings beat and revenue growth, and the company declared a $0.90 quarterly dividend (ex-dividend April 9, payable May 15), which supports income-oriented demand. John Doyle Sells 16,655 Shares of Marsh & McLennan Companies (NYSE:MRSH) Stock
• Positive Sentiment: Analyst coverage is mixed-to-favorable: some firms maintained or raised targets (including a Raymond James upgrade) and consensus price targets remain above the current level, which can underpin buying interest. Analysts Set Marsh (NYSE:MRSH) Target Price at $207.38
• Neutral Sentiment: Market write-ups and peer comparisons continue to circulate (analyst notes / comparison pieces) but don’t introduce new company-specific catalysts; they provide context for relative valuation and may influence longer-term flows rather than intraday moves. Comparing Marsh & McLennan Companies (NYSE:MRSH) & Health In Tech (NASDAQ:HIT)
• Negative Sentiment: CEO John Q. Doyle sold 16,655 shares (~$3.05M at ~$183.30), reducing his stake by ~12.5%. Insider selling can weigh on sentiment because it may be interpreted as reduced insider conviction or a signal of liquidity needs. John Doyle Sells 16,655 Shares of Marsh & McLennan Companies (NYSE:MRSH) Stock
• Negative Sentiment: Legal risk: a Bloomberg Law ruling requires Marsh & McLennan to face a fiduciary-breach case tied to health-plan management — this introduces litigation risk and potential remediation costs that can cap valuation multiple until resolved. Marsh & McLennan Must Face Health Plan Fiduciary Breach Case

Marsh & McLennan Companies Company Profile

Marsh & McLennan Companies (NYSE: MMC) is a global professional services firm headquartered in New York City that provides advice and solutions in the areas of risk, strategy and people. Founded in 1905, the company has grown into a diversified group of businesses focused on insurance brokerage and risk management, reinsurance, human capital and investment consulting, and management consulting. Its long history and scale position it as a prominent adviser to corporations, governments and other institutions seeking to manage risk and optimize human and financial capital.

The firm operates through several well-known subsidiaries and business units that specialize in distinct services.